Optometry Practice EBITDA Valuation Multiples: What Buyers Are Paying in 2024
From solo retiring ODs to PE-backed roll-ups, here is how acquirers value independent optometry practices across every performance tier.
Independent optometry practices typically trade at 3x–5.5x EBITDA in the lower middle market. Valuations reflect patient base loyalty, insurance payer mix, optical retail revenue, and owner dependence. PE-backed consolidators may pay at the high end for established practices with associate optometrists and modern diagnostic equipment.
Optometry Practice EBITDA Multiple Ranges by Tier
| Business Tier | EBITDA Range | Multiple Range | Notes |
|---|---|---|---|
| Entry-Level / Turnaround | $150K–$300K | 3.0x–3.5x | Heavy owner dependence, aging equipment, declining patient volume, or narrow single-payer insurance mix limiting buyer appetite. |
| Stable Independent Practice | $300K–$500K | 3.5x–4.5x | 2,000+ active patients, diversified payer mix, functioning recall system, and clean financials. Core SBA-financed acquisition target. |
| Strong Growth Practice | $500K–$800K | 4.5x–5.0x | Associate optometrists in place, optical retail dispensary, modern OCT and digital refraction technology, and 70%+ patient retention rates. |
| Platform-Ready / PE Target | $800K+ | 5.0x–5.5x | Multi-location or scalable single location with documented systems, diversified revenue, and strong team. Attractive to regional vision care consolidators. |
What Drives Optometry Practice Multiples
Owner Dependence
Negative impactPractices where all patient relationships rest on the selling OD face steep valuation discounts. Buyers pay a premium when associate optometrists already deliver a significant portion of patient care.
Insurance Payer Mix
Positive or Negative impactHeavy reliance on a single managed vision plan like VSP or EyeMed compresses multiples. Diversified payer mix with private pay and optical retail revenue supports higher valuations.
Active Patient Count and Recall Systems
Positive impactPractices with 2,000+ active patients and documented recall programs achieving 70%+ return rates demonstrate predictable recurring revenue that buyers price at premium multiples.
Optical Retail Revenue
Positive impactAn attached dispensary generating eyewear and contact lens sales adds high-margin revenue that pure medical practices lack, materially improving EBITDA margins and supporting higher multiples.
Equipment Age and Capital Needs
Negative impactOutdated or fully depreciated diagnostic equipment signals near-term capital expenditure. Buyers discount offers to account for OCT replacement, digital refraction upgrades, or lane modernization costs.
Recent Market Trends
PE-backed vision care platforms have compressed deal timelines and pushed multiples toward the high end for scalable practices. SBA 7(a) lending remains active for OD-to-OD transfers. Buyer demand for telemedicine capability and optical retail revenue has increased as managed care reimbursement rates face compression from VSP and EyeMed contracts.
Sample Optometry Practice Transactions
Solo OD retirement sale, suburban market, 2,400 active patients, diversified payer mix, clean financials, associate in place for transition
$380K
EBITDA
4.2x
Multiple
$1.6M
Price
Two-location group practice, optical dispensary, OCT and digital refraction technology, associate optometrist employed, PE platform acquisition
$720K
EBITDA
5.1x
Multiple
$3.67M
Price
Single-location practice, heavy VSP concentration, aging equipment, no associate, retiring OD with 18-month transition agreement
$260K
EBITDA
3.3x
Multiple
$858K
Price
EBITDA Valuation Estimator
Get your Optometry Practice business value range instantly
Industry: Optometry Practice · Multiples based on 3.5x–4.5x (Stable Independent Practice)
Powered by Deal Flow OS
dealflow-os.com · Free M&A tools for every stage of the deal
Frequently Asked Questions
What EBITDA multiple should I expect when selling my optometry practice?
Most independent optometry practices sell at 3x–5.5x EBITDA. Your specific multiple depends on patient volume, payer mix, owner dependence, equipment condition, and whether associate optometrists are in place.
Do PE-backed vision care consolidators pay higher multiples than individual OD buyers?
Yes. PE platforms frequently pay 5x–5.5x for scalable practices with associate optometrists and modern equipment, while individual OD buyers using SBA financing typically target 3.5x–4.5x.
How does my optical dispensary affect my practice valuation?
Optical retail revenue significantly improves EBITDA margins and signals revenue diversification. Buyers view dispensary income favorably, often supporting multiples at the higher end of the 3x–5.5x range.
Can I sell my optometry practice using SBA financing?
Yes. Optometry practices are SBA 7(a) eligible. Most OD-to-OD transfers are financed with 80–90% SBA debt, a 10–20% buyer equity injection, and an optional seller note covering 10–15% of the purchase price.
More Optometry Practice Guides
Find Optometry Practice businesses at the right price
DealFlow OS surfaces acquisition targets with seller signals and outreach angles. Free to join.
Start finding deals — freeNo credit card required